Issues for Women with Epilepsy

Area of Science:

• Reproductive endocrinology
• Neuropharmacology
• Women's health

Background:

• Epilepsy and antiepileptic drugs (AEDs) significantly interact with female reproductive systems.
• These interactions involve sex steroid hormone pathways, affecting menstruation, reproduction, pregnancy, and menopause.
• Hormonal fluctuations can influence seizure frequency and alter AED pharmacokinetics.

Purpose of the Study:

• To review the complex interplay between epilepsy, AEDs, and female reproductive health.
• To highlight the impact on menstrual cycles, contraception, pregnancy outcomes, and menopause.
• To discuss the challenges in managing epilepsy during pregnancy.

Main Methods:

• Literature review of studies on epilepsy, AEDs, and reproductive health.
• Analysis of hormonal influences on seizure activity and AED levels.
• Examination of pregnancy outcomes and teratogenic risks associated with AEDs.

Main Results:

• Approximately 33% of women with epilepsy experience increased seizure frequency around menstruation (perimenstrual/periovulatory periods).
• Some women exhibit increased seizure frequency during pregnancy.
• Certain AEDs are linked to cognitive and behavioral teratogenesis, posing risks to fetal development.

Conclusions:

• Management of epilepsy in women requires consideration of hormonal fluctuations and reproductive status.
• Balancing maternal seizure control with fetal safety is critical during pregnancy.
• Avoiding specific AEDs with known teratogenic effects is recommended during gestation.